glp 1 coach certification ISSA Launches GLP-1 Support Course for Trainers 🏅 Certified GLP-1 Exercise Specialist

GLP-1 receptor agonists, such as Ozempic and Wegovy, have emerged as powerful options in the fight against obesity

At 12 months, weight loss persisted at around 4%, with variability between agents, most notably liraglutide

Claimants are seeking compensation for their suffering, including medical expenses, loss of quality of life, and other damages

Most commercial Aetna plans cover Wegovy and Zepbound with prior authorization, costing members roughly $25 to $100 per month after PA approval

Randomized, placebo-controlled study of once-weekly exenatide in 44 non-diabetic, obese children ages 1018, which found a 2.3% decrease in BMI with exenatide compared with placebo

Before anyone tries this as part of a definition phase it is worth asking a more basic question: is microdosing glp 1 even an evidence based strategy or is it another internet experiment on your metabolism